Noblejas-López, M.d.M.; Baliu-Piqué, M.; Nieto-Jiménez, C.; Cimas, F.J.; Morafraile, E.C.; Pandiella, A.; Corbi, Á.L.; Győrffy, B.; Ocaña, A.
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation. Int. J. Mol. Sci. 2021, 22, 3836.
https://doi.org/10.3390/ijms22083836
AMA Style
Noblejas-López MdM, Baliu-Piqué M, Nieto-Jiménez C, Cimas FJ, Morafraile EC, Pandiella A, Corbi ÁL, Győrffy B, Ocaña A.
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation. International Journal of Molecular Sciences. 2021; 22(8):3836.
https://doi.org/10.3390/ijms22083836
Chicago/Turabian Style
Noblejas-López, María del Mar, Mariona Baliu-Piqué, Cristina Nieto-Jiménez, Francisco J. Cimas, Esther C. Morafraile, Atanasio Pandiella, Ángel L. Corbi, Balázs Győrffy, and Alberto Ocaña.
2021. "Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation" International Journal of Molecular Sciences 22, no. 8: 3836.
https://doi.org/10.3390/ijms22083836
APA Style
Noblejas-López, M. d. M., Baliu-Piqué, M., Nieto-Jiménez, C., Cimas, F. J., Morafraile, E. C., Pandiella, A., Corbi, Á. L., Győrffy, B., & Ocaña, A.
(2021). Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation. International Journal of Molecular Sciences, 22(8), 3836.
https://doi.org/10.3390/ijms22083836